Jefferies Financial Group Forecasts Strong Price Appreciation for Henry Schein (NASDAQ:HSIC) Stock

Henry Schein (NASDAQ:HSIC) had its price objective upped by Jefferies Financial Group from $77.00 to $80.00 in a note issued to investors on Thursday,Benzinga reports. The firm currently has a “hold” rating on the stock. Jefferies Financial Group’s target price points to a potential upside of 6.71% from the stock’s current price.

Several other research analysts also recently issued reports on HSIC. StockNews.com raised shares of Henry Schein from a “sell” rating to a “hold” rating in a research report on Thursday, November 7th. Barrington Research reiterated an “outperform” rating and issued a $82.00 price objective on shares of Henry Schein in a research report on Wednesday, November 6th. Mizuho started coverage on shares of Henry Schein in a research report on Wednesday, December 4th. They set a “neutral” rating and a $75.00 price target for the company. Evercore ISI boosted their price objective on shares of Henry Schein from $70.00 to $74.00 and gave the stock an “in-line” rating in a research report on Tuesday, October 8th. Finally, Bank of America upgraded Henry Schein from an “underperform” rating to a “buy” rating and increased their target price for the company from $69.00 to $84.00 in a report on Monday, January 6th. Seven equities research analysts have rated the stock with a hold rating, five have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $79.30.

Henry Schein Price Performance

HSIC opened at $74.97 on Thursday. The stock’s 50-day moving average price is $72.99 and its 200 day moving average price is $70.96. The company has a current ratio of 1.42, a quick ratio of 0.82 and a debt-to-equity ratio of 0.46. Henry Schein has a 12-month low of $63.67 and a 12-month high of $82.63. The firm has a market cap of $9.35 billion, a price-to-earnings ratio of 30.85, a PEG ratio of 2.04 and a beta of 0.89.

Henry Schein (NASDAQ:HSIC) last announced its quarterly earnings data on Tuesday, November 5th. The company reported $1.22 EPS for the quarter, topping analysts’ consensus estimates of $1.17 by $0.05. The business had revenue of $3.17 billion during the quarter, compared to the consensus estimate of $3.24 billion. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The business’s revenue for the quarter was up .4% on a year-over-year basis. During the same period in the previous year, the company posted $1.32 earnings per share. As a group, sell-side analysts expect that Henry Schein will post 4.78 earnings per share for the current year.

Insider Activity at Henry Schein

In other Henry Schein news, COO Michael S. Ettinger sold 12,240 shares of the firm’s stock in a transaction on Monday, November 18th. The stock was sold at an average price of $75.00, for a total value of $918,000.00. Following the sale, the chief operating officer now directly owns 87,706 shares in the company, valued at approximately $6,577,950. This trade represents a 12.25 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Insiders own 1.14% of the company’s stock.

Hedge Funds Weigh In On Henry Schein

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the business. Clarkston Capital Partners LLC raised its position in shares of Henry Schein by 5.4% during the 3rd quarter. Clarkston Capital Partners LLC now owns 1,397,805 shares of the company’s stock worth $101,900,000 after buying an additional 71,560 shares in the last quarter. Nuance Investments LLC increased its stake in shares of Henry Schein by 22.3% during the third quarter. Nuance Investments LLC now owns 2,278,081 shares of the company’s stock valued at $166,072,000 after acquiring an additional 414,748 shares during the period. SG Americas Securities LLC raised its holdings in Henry Schein by 1,622.3% during the third quarter. SG Americas Securities LLC now owns 458,828 shares of the company’s stock worth $33,449,000 after purchasing an additional 432,187 shares in the last quarter. B. Metzler seel. Sohn & Co. Holding AG acquired a new stake in Henry Schein in the third quarter worth approximately $515,000. Finally, MBB Public Markets I LLC bought a new position in Henry Schein during the 2nd quarter valued at $611,000. 96.62% of the stock is owned by institutional investors.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.